Abstract
<b>Introduction:</b> Inhaled corticosteroids (ICS) reduce exacerbations in asthma. However, the different mechanisms underlying the effect of these drugs in T2-high and T2-low phenotypes are largely unknown. <b>Aim:</b> To evaluate the effect of ICS treatment on bronchial epithelial response to TLR3 stimulation in T2-high and T2-low asthma patients. <b>Methods:</b> Bronchial epithelial cells (BECs) from patients with T2-high (FeNO>25ppb; N=8) and T2-low (N=9) asthma, before and after inhaled budesonide (6 weeks; 1600mg/day), were used. Poly(I:C) (TLR3 agonist) was used as viral mimic. Proteomic (LC-MS/MS) and RTqPCR analyses were performed in BECs homogenates, and ELISA in BECs supernatants. <b>Results:</b> 171 proteins were upregulated in poly(I:C)-stimulated BECs from T2-high/atopic vs. T2-low/non-atopic patients (p<0.05/FC>1.5), including proteins from biological process categories related to immune system (e.g., GO:0045087, GO:0016032, or GO:0034097). ICS treatment reduced this exaggerated BECs response in T2-high patients (4 proteins up, 220 down; p<0.05/FC>1.5), whereas the opposite effect was found in T2-low asthma (34 up; 7 down; p<0.05/FC>1.5). Moreover, an increased IFN-β release in response to poly (I:C) was found in BECs from T2-low patients after ICS treatment (p<0.05), and the same was shown for TNF-α both at gene (p=0.05) and protein (p<0.05) level. <b>Conclusion:</b> Budesonide treatment had differing but beneficial effects on the airway epithelial response to a viral mimic in both T2-high and T2 low asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.